Christopher Shea to Interleukin-2
This is a "connection" page, showing publications Christopher Shea has written about Interleukin-2.
Connection Strength
0.071
-
Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901. J Immunother. 2006 Jan-Feb; 29(1):95-101.
Score: 0.065
-
Antigen receptor-mediated anergy in resting T lymphocytes and T cell clones. Correlation with lymphokine secretion patterns. J Immunol. 1992 Sep 15; 149(6):1921-6.
Score: 0.006